Stock PAND PANDION THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Pandion Therapeutics, Inc.

Equities

PAND

US6983401067

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PANDION THERAPEUTICS : Morgan Stanley Downgrades Pandion Therapeutics to Equal Weight From Overweight, Adjusts PT to $60 From $25
MT
PANDION THERAPEUTICS : SVB Leerink Downgrades Pandion Therapeutics to Market Perform From Outperform; Price Target is $60
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PAND Stock
  4. News Pandion Therapeutics, Inc.
  5. Analyst Reco.